Northwestern Mutual Wealth Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
SCM
CAM
Northwestern Mutual Wealth Management's TGTX Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its TG Therapeutics (TGTX) stake by 2.8% in Q2 2026, selling an estimated $7K and leaving 5,895 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.
Northwestern Mutual Wealth Management first reported a position in TGTX in Q3 2016 and has held it in 18 quarters since. The position peaked at $468K in Q3 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.
- Northwestern Mutual Wealth Management held 5,895 shares of TG Therapeutics worth $324K as of Q2 2026.
- Northwestern Mutual Wealth Management sold 171 TG Therapeutics shares in Q2 2026, an estimated $7K.
- TG Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1798 holding.
- Northwestern Mutual Wealth Management first reported a position in TG Therapeutics in Q3 2016 and has held it in 18 quarters since.
- Northwestern Mutual Wealth Management's TG Therapeutics position peaked at $468K in Q3 2024.
- 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.